Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

ATAI Life Sciences N.V. - Common Shares (NQ:ATAI)

2.420 -0.060 (-2.42%)
Streaming Delayed Price Updated: 3:46 PM EDT, Jun 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ATAI Life Sciences N.V. - Common Shares

< Previous 1 2
...
14 15 16 17 18 19 20 21 22
...
27 28 Next >
Cathie Wood Continues Investing In Psychedelics, She Bought Over 3M Atai Shares In July Alone
Several weeks ago, Cathie Wood's ARK Fund (BATS: ARKG) invested in the biotech psychedelics sector, specifically in major player 
Via Benzinga
ATAI Life Sciences, Allied Among Top Psychedelic Movers Of Today
GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 7.61% at $3.82 
Via Benzinga
ATAI Life Sciences, Mind Medicine Among Top Psychedelic Movers Of Today
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 4.95% at $0.34 
Via Benzinga
July Update: Psychedelic Compounds-Based Drug Stocks Index Up 23%; Remains Down 44% YTD
Of the 107 clinical-stage psychedelic drug stocks trading on North American stock exchanges only 8 have market caps of $50M or more, and trade for US$0.50/share or more. 
Via Talk Markets
Psychedelic Stock Gainers And Losers From July 29, 2022
GAINERS: Numinus Wellness (OTC:NUMIF) shares closed up 11.30% at $0.22 
Via Benzinga
InvestorNewsBreaks – Atai Life Sciences (NASDAQ: ATAI) Featured in Analysis Report
Via Investor Brand Network
Topics Derivatives
Exposures Derivatives
Allied, Cybin Among Top Psychedelic Movers Of Today
GAINERS: Allied (OTC:ALID) shares closed up 19.46% at $0.55 
Via Benzinga
Allied, Compass Pathways Among Top Psychedelic Movers Of Today
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 5.66% at $16.06 
Via Benzinga
Ketamine Ushering in New Era in the Pharmacology Therapies for Neurological Disorders
Palm Beach, FL – July 27, 2022 – For years, ketamine was known for its use as an anesthetic or as a recreational drug. Its ability to provide quick and safe sedation saved many lives during the Vietnam... 
Via FinancialNewsMedia
Topics Law Enforcement
Exposures Legal
Allied, GH Research Among Top Psychedelic Movers Of Today
GAINERS: Allied (OTC:ALID) shares closed up 22.11% at $0.55 
Via Benzinga
Allied, Revive Therapeutics Among Top Psychedelic Movers Of Today
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 2.76% at $14.91 LOSERS: 
Via Benzinga
Psychedelic Stock Gainers And Losers From July 22, 2022
GAINERS: Allied (OTC:ALID) shares closed up 11.04% at $0.50 
Via Benzinga
Allied, ATAI Life Sciences Among Top Psychedelic Movers Of Today
GAINERS: LOSERS: Allied (OTC:ALID) shares closed down 10.00% at $0.45 
Via Benzinga
Dear Psychedelic Stocks Fans, Watch This Key Catalyst
Psychedelic stocks are in focus following new legislation from both the Senate and the House that has bipartisan support. 
Via InvestorPlace
Psychedelic Stock Gainers And Losers From July 20, 2022
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 10.53% at $15.11 
Via Benzinga
Seelos Therapeutics, Numinus Wellness Among Top Psychedelic Movers Of Today
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 8.09% at $0.93 
Via Benzinga
Allied, Revive Therapeutics Among Top Psychedelic Movers Of Today
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 7.69% at $13.02 
Via Benzinga
The 8 Largest Psychedelic Compounds-Based Drug Stocks: A Financial Assessment
A look at the stock performances of the 8 largest clinical-stage companies involved in the research and development of psychedelic compound-based drugs. 
Via Talk Markets
Awakn Life Sciences Receives Funding From UK Government To Identify Most Efficient Go-To-Market Pathway For Proprietary Ketamine-Assisted Therapy
Awakn Life Sciences Corp. (OTCQB: AWKNF) reported it secured funding from Innovate UK to identify the quickest and most cost-effective route to market in both the U.K. and the U.S. 
Via Benzinga
Allied, Compass Pathways Among Top Psychedelic Movers Of Today
GAINERS: Allied (OTC:ALID) shares closed up 7.05% at $0.52 
Via Benzinga
5 Top Stocks Cathie Wood Bought This Week
Cathie Wood is still buying the dip and believes that deflationary forces may soon show out. Here are five top stocks she bought this week. 
Via InvestorPlace
Psychedelic Stock Gainers And Losers From July 14, 2022
GAINERS: Allied (OTC:ALID) shares closed up 7.63% at $0.49 
Via Benzinga
Psychedelic Stock Gainers And Losers From July 13, 2022
GAINERS: Cybin (AMEX:CYBN) shares closed up 6.16% at $0.61 
Via Benzinga
Psychedelic Companies With Solid Fundamentals Will Survive A Downturn In The Recession-Ridden Market
Article by Jason Najum.  Psychedelic startups face a more challenging time raising capital amid market volatility, the prospect of rate hikes, and recession fears, but that could ultimately help the... 
Via Benzinga
Allied, Compass Pathways Among Top Psychedelic Movers Of Today
GAINERS: Mind Medicine (NASDAQ:MNMD) shares closed up 4.15% at $0.66 
Via Benzinga
Psychedelic Drug Stocks Index Up Last Week, Still Down YTD
The psychedelic Compounds-Based Drug Stocks Index was +24.0% last week; +33.5% in the last 5 weeks; but still -44.0% YTD. 
Via Talk Markets
Psychedelic Stock Gainers And Losers From July 11, 2022
GAINERS: Allied (OTC:ALID) shares closed up 14.67% at $0.54 
Via Benzinga
Allied, GH Research Among Top Psychedelic Movers Of Today
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 9.74% at $12.85 
Via Benzinga
5 New Cathie Wood Stocks to Watch Right Now
Cathie Wood remains bullish on staple ARK names like Tesla and Teladoc. Still, the fund manager has added several new companies to her ETFs. 
Via InvestorPlace
Psychedelic Stock Gainers And Losers From July 7, 2022
GAINERS: Allied (OTC:ALID) shares closed up 14.62% at $0.54 
Via Benzinga
< Previous 1 2
...
14 15 16 17 18 19 20 21 22
...
27 28 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.